FDA Tag

On 7 August 2023, the U.S. Food and Drug Administration, issued draft guidance on cosmetic product facility registrations and product listings, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The draft guidance will assist stakeholders with cosmetic product facility registration and product listing submissions to FDA, by describing who is responsible for making the registration and listing...

On 29 December 2022, President Biden signed into law the Consolidated Appropriations Act, 2023. Modernization of Cosmetic Regulation. Act, “MoCRA”, is the first major update to the Food and Drug Administration's (FDA) cosmetics authorities since 1938 and introduces significant changes. MOCRA'S KEY PROVISIONS Sec. 605 Adverse Effect Adverse effects caused by the use of the product must be reported to the FDA within...